About Boehringer Ingelheim Animal Health

As the second largest animal health business in the world, Boehringer Ingelheim is committed to improving animal health. With more than 10,000 employees worldwide, Boehringer Ingelheim Animal Health has products available in more than 150 markets and a global presence in 99 countries. For more information about Boehringer Ingelheim Animal Health, click here.

Boehringer Ingelheim

Innovative medicines for people and animals have for more than 130 years been what the research-driven pharmaceutical company Boehringer Ingelheim stands for. Boehringer Ingelheim is one of the industry’s top 20 pharmaceutical companies and to this day remains family-owned. Day by day, some 50,000 employees create value through innovation for the three business areas human pharmaceuticals, animal health and biopharmaceutical contract manufacturing. In 2016, Boehringer Ingelheim achieved net sales of around 15.9 billion euros. With more than three billion euros, R&D expenditure corresponds to 19.6 per cent of net sales.

Social responsibility comes naturally to Boehringer Ingelheim. That is why the company is involved in social projects, such as the “Making More Health” initiative. Boehringer Ingelheim also actively promotes workforce diversity and benefits from its employees’ different experiences and skills. Furthermore, the focus is on environmental protection and sustainability in everything the company does.

More information about Boehringer Ingelheim can be found on www.boehringer-ingelheim.com or in our annual report: http://annualreport.boehringer-ingelheim.com.

 

 

Boehringer Inglhiem official AQHA products are GastroGard (omeprazole), UlcerGard (omeprazole) and Equioxx(firocoxib).

Learn more about these three important Merial horse health products:

UlcerGard

Prevention is the best medicine when it comes to stomach ulcers, which can reduce your horse’s performance and can even lead to death.1 

Horses are extremely sensitive to stress. Even events that many horse owners consider to be routine can be stressful enough to contribute to stomach ulcer development, sometimes in as few as five days.2 In addition to travel,3 training3 and competition3, changes in routine, 4 illness or injury, 5 and limited turnout or grazing5 can cause stomach ulcers. And unfortunately, horses with stomach ulcers often suffer in silence before they are diagnosed and the horse owner never knows it. 

You guard your horse against injuries. You guard against disease. With UlcerGard, you can guard against equine stomach ulcers. UlcerGard is the only product that’s approved by the FDA to prevent equine stomach ulcers.* Best of all, it’s easy to use. Your veterinarian can supply you with UlcerGard and discuss management tips that also can help reduce the stress factors that cause stomach ulcers. 

*When treated for eight to 28 days, UlcerGard is proven to effectively prevent gastric ulcers in horses exposed to stressful conditions.

Important safety information:

UlcerGard can be used in horses that weigh at least 600 pounds. Safety in pregnant mares has not been determined.

Learn more about UlcerGard.
Read the UlcerGard product label.

1 Radostits OM, et al. Veterinary Medicine: A textbook of the diseases of cattle, horses, sheep, pigs and goats. Philadelphia: WB Saunders Co.; 007:237-241. 
2 McClure SR, Carithers DS, Gross SJ, Murray MJ. Gastric ulcer development in horses in a simulated show or training environment. J Am Vet Med Assoc 2005;227(5):775-777. 
3 UlcerGard product label. 
4 Equine Gastric Ulcer Council. Recommendations for the diagnosis and treatment of Equine Gastric Ulcer Syndrome (EGUS). Equine Vet Educ 1999;11:262-272. 
5Murray MJ. Overview of equine gastroduodenal ulceration. AAEP Proccedings 1997;43:382-387. 


GastroGard

Your horse can’t tell you when he’s suffering from equine gastric ulcer syndrome. This painful, potentially life-threatening condition1 can affect most horses — of all ages, breeds and disciplines.

Only your veterinarian can accurately diagnose equine stomach ulcers, but you can help. Watch your horse for common signs of stomach ulcers and report them to your veterinarian as soon as possible. Signs may include changes in drinking and eating behavior, weight loss, change in attitude, recurrent colic, change in haircoat and less than optimal performance.2 Watching for and reporting these signs will help you respond quickly and reduce pain and serious damage to your horse.

Your veterinarian can accurately diagnose, treat and heal stomach ulcers. Your veterinarian will use an endoscope or other proven techniques to diagnose equine stomach ulcers. If diagnosed, your vet will probably prescribe GastroGard. GastroGard is the No. 1 veterinarian-recommended product for treating stomach ulcers3 — and the only medication that’s proven and approved by the FDA to treat equine stomach ulcers.

How common are equine stomach ulcers? Equine stomach ulcers have been found in horses of a wide variety of breeds, disciplines and ages, including:

  • 93 percent of racehorses4
  • 63 percent of nonracing performance horses5
  • 51 percent of foals5

Important safety information: 

Safety of GastroGard in pregnant or lactating mares has not been determined. 
For prescription information for GastroGard, click here.

Learn more about GastroGard.
Read the GastroGard product label.
Read the GastroGard prescribing information.

1 Radostits OM, et al. Veterinary Medicine: A textbook of the diseases of cattle, horses, sheep, pigs and goats. Philadelphia: WB Saunders Co.; 007:237-241. 
2 Equine Gastric Ulcer Council. Recommendations for the diagnosis and treatment of Equine Gastric Ulcer Syndrome (EGUS). Equine Vet Educ 1999;11:262-272. 
3 Market Directions Study. Data on file at Merial. 
4 Murray MJ. Overview of equine gastroduodenal ulceration. AAEP Proccedings 1997;43:382-387. 
5 Mitchell RD. Prevalence of gastric ulcers in hunter/jumper and dressage horses evaluated for poor performance. Association for Equine Sports Medicine September 2001.


 

EquioxxEquioxx

Equioxxis the first and only coxib NSAID approved for horses and provides 24 hours of prescription pain relief* in just one daily dose.1 Other NSAIDs must be given multiple times a day to provide consistent, round-the-clock therapeutic levels of pain relief – possibly leaving horses vulnerable to a roller coast effect of pain and pain relief.2,3,4 

Equioxxis the only NSAID approved for use for up to 14 consecutive days by both AQHA and the United States Equestrian Federation when used at the recommended dose at least 12 hours prior to competing.5,6 

An important part of a product’s effectiveness is that it be used properly. Convenient administration of the product is also essential. According to 95 percent of horse owners in a study, Equioxxdelivers a unique combination of properties that make it convenient to use: 7

 

  • Once daily dosing8
  • Palatable oral paste formulation9
  • Well accepted by 98 percent of horses10
  • Can be used with all nonbreeding horses at least 1 year old8
  • Can be administered with or without feed or hay8

Important Safety Information: 

As with any prescription medication, prior to use, a veterinarian should perform a physical examination and review the horse’s medical history. A veterinarian should advise horse owners to observe for signs of potential drug toxicity. As a class, nonsteroidal anti-inflammatory drugs may be associated with gastrointestinal, hepatic and renal toxicity. Use with other NSAIDs, corticosteroids or nephrotoxic medication should be avoided. Equioxxhas not been tested in horses less than 1 year of age or in breeding horses, or pregnant or lactating mares. For additional information please refer to the prescribing information or visit www.Equioxx.com

Learn more about Equioxx. 
Read the Equioxx product label.
Read the Equioxx prescribing information.

* Joint pain and inflammation associated with equine osteoarthritis, also called degenerative joint disease.

1 Data on file at Merial. 
2 Tobin T, Chay S, Kamerling S, Woods WE, Weckman TJ, Blake JW, Lees, P. Phenylbutazone in the horse: a review. J Vet Pharmacol Ther. 1986(1):1-25. 
3 The United States Pharmacopeial Convention. Flunixin. 2007. Available at: http://usp.org/pdf/EN/veterinary/flunixin.pdf. Accessed March 29, 2009. 
4 The United States Pharmacopeial Convention. Phenylbutazone. 2004. Available at: http://www.usp.org/pdf/EN/veterinary/phenylbutazone.pdf. Accessed March 29, 2009. 
5 American Quarter Horse Association. Show rules and regulations. Official Handbook of Rules and Regulations 2008:128. 
6 United States Equestrian Federation. Drugs and medications guidelines. 2007:2-3. Available at: http://www.usef.org/documents/competitions/2007/2007DrugsMedsGuidelines.pdf. Accessed February 20, 2009. 
7 Data on file at Merial, Multicenter Field Study, PR&D 0084201-07/09-10. 
8 Equioxxproduct label. 
9 EquioxxExperience Trial Results; data on file at Merial. 
10 EquioxxFreedom of Information Summary.

®Equioxxis a registered trademark of Merial Limited. ®UlcerGard and GastroGard are registered trademarks of the AstraZeneca Group of Companies. All other brand names are trademarks of their respective holders. ©2010 Merial Limited, Duluth, GA. All rights reserved. EQUILGN1015 (08/10)

 

Support from AQHA Corporate Partner Boehringer Ingelheim makes these AQHA events and programs possible:

 

Join or Renew Your AQHA Membership